Dipeptidyl peptidase-4 inhibitor (DPP4i) is a widely used drug for T2D that promotes insulin secretion and lowers glucagon levels by inhibiting the dipeptidyl peptidase-4 enzyme. The gene discussed is DPP4; the disease is type 2 diabetes mellitus.